Table S2 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
crossref（2024）
摘要
Ongoing clinical trial of phosphorylation-associated small molecule drugs and anti-PD-1/PD-L1 combination
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要